REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 5 filers reported holding REVANCE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208 | -10.3% | 18,103 | +97.6% | 0.00% | 0.0% |
| Q2 2023 | $232 | -20.5% | 9,161 | +1.1% | 0.00% | 0.0% |
| Q1 2023 | $292 | +42.4% | 9,061 | -18.3% | 0.00% | 0.0% |
| Q4 2022 | $205 | -99.9% | 11,095 | +2.7% | 0.00% | -50.0% |
| Q3 2022 | $292,000 | +97.3% | 10,806 | +0.7% | 0.00% | +100.0% |
| Q2 2022 | $148,000 | -40.3% | 10,735 | -15.7% | 0.00% | 0.0% |
| Q1 2022 | $248,000 | -25.7% | 12,731 | -37.8% | 0.00% | -50.0% |
| Q4 2021 | $334,000 | -49.1% | 20,464 | -13.1% | 0.00% | -60.0% |
| Q3 2021 | $656,000 | -6.0% | 23,551 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $698,000 | -11.6% | 23,551 | -16.6% | 0.01% | -28.6% |
| Q1 2021 | $790,000 | -9.7% | 28,252 | -8.5% | 0.01% | -36.4% |
| Q4 2020 | $875,000 | – | 30,869 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |